Clinically effective HIV-1 protease inhibitors

Drug Discovery Today

Volumn 2, Issue 7, 1997, Pages 261-272

  Vacca, Joseph P ^a   Condra, Jon H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; DRUG DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; STRUCTURE ACTIVITY RELATION; VIRUS RESISTANCE;

EID: 0030849517     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(97)01053-2     Document Type: Review

References (48)

1. Ratner, L. et al. (1985) Nature 313, 277-284
2. Toh, H. et al. (1985) Nature 315, 691
3. Kohl, N.E. et al. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4686-4690
4. Bilello, J.A. et al. (1995) J. Infect. Dis. 171, 546-551
5. Bilello, J.A. et al. (1996) Antimicrob. Agents Chemother. 40, 1491-1497
6. Huff, J.R. (1991) J. Med. Chem. 34, 2305-2314
7. Tomasselli, A.G. et al. (1991) Chimica Oggi, May, 6-27
8. Pearl, L.H. and Taylor, W.R. (1987) Nature 329, 351-354
9. Johnston, M.I., Alluadeen, H.S. and Sarver, N. (1989) Trends Pharmacol. Sci. 10, 305-307
10. Dunn, B.M. and Kay, J. (1990) Antiviral Chem. Chemother. 3, 3-8
11. Greenlee, W.J. (1990) J. Med. Res. Rev. 10, 173
12. Dreyer, G.B. et al. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9752-9756
13. Roberts, N.A. et al. (1990) Science 248, 358-361
14. Roberts, N.A. and Redshaw, S. (1993) in The Search for Antiviral Drugs (Adams, J. and Merluzzi, V.J., eds). pp. 129-151, Birkhäuser
15. Erickson, J. et al. (1990) Science 249, 527-533
16. Kempf, D.J. et al. (1990) J. Med. Chem. 33, 2687-2689
17. Kempf, D.J. et al. (1993) J. Med. Chem. 36, 320-330
18. Reedijk, M. et al. (1995) Antimicrob. Agents Chemother. 39, 1559-1564
19. Kempf, D.J. et al. (1994) Bioorg. Med. Chem. 2, 847-858
20. Kempf, D.J. et al. (1995) Proc. Natl Acad. Sci. U. S. A. 92, 2484-2488
21. Kumar, G.N. et al. (1996) J. Pharmacol. Exp. Ther. 277, 423-431
22. Vacca, J.P. et al. (1991) J. Med. Chem. 34, 1225
23. Lyle, T.A. et al. (1991) J. Med. Chem. 34, 1228-1230
24. Thompson, W.J. et al. (1992) J. Med. Chem. 35, 1685-1701
25. Lin, J.H., Chen, I-Wu and King, J. (1992) J. Pharmacol. Exp. Ther. 263, 105-111
26. Holloway, M. et al. (1994) J. Med. Chem. 38, 305-317
27. Vacca, J.P. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4096-4100
28. Dorsey, B.D. et al. (1995) J. Med. Chem. 38, 305-317
29. Lin, J.H. et al. (1995) J. Pharmacol. Exp. Ther. 274, 264-269
30. Kalish, V. et al. (1995) Eur. J. Med. Chem. 30, S201-214
31. Shetty, B.K. et al. (1996) Antimicrob. Agents Chemother. 40, 110-114
32. Package insert for saquinavir
33. Collier, A. et al. (1996) New Engl. J. Med. 334, 1011-1017
34. Schapiro, J.M. et al. (1996) Ann. Intern. Med. 124, 1039-1050
35. Package insert for ritonavir
36. Danner, S.A. et al. (1995) New Engl. J. Med. 333, 1528-1533
37. Package insert for indinavir
38. Stein, D.S. et al. (1996) AIDS 10, 485-492
39. Package insert for nelfinavir
40. Moyle, G.J. et al. (1996) 11th International Conference on AIDS, 7-12 July, Vancouver, Canada, Abstr. Mo.B173
41. Gathe, J., Jr et al. (1996) 11th International Conference on AIDS, 7-12 July, Vancouver, Canada, Abstr. Mo.B413
42. Kim, E.E. et al. (1995) J. Am. Chem. Soc. 17, 1181-1182
43. Painter, G. et al. (1996) Drugs Future 21, 347-350
44. Ghosh, A.K. et al. (1993) J. Med. Chem. 36, 292-294
45. Livingston, D.J. et al. (1995) J. Infect. Dis. 172, 1238-1245
46. St Clair, M.H. et al. (1996) Antiviral Res. 29, 53-56
47. Schooley, R.T. et al. (1996) 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, 16-19 September, New Orleans, USA, Abstr. LB7a
48. Condra, J.H. et al. (1995) Nature 374, 569-571